Blog Layout

Haematologist Dr Marsali Maclean joins Ballarat Cancer Care
February 16, 2025

Haematologist Dr Marsali Maclean joins Ballarat Cancer Care

Dr Marsali Maclean is a clinical haematologist who treats blood cancers and non-malignant blood disorders. She has a broad range of experience within haematology and has recent experience of emerging cutting-edge therapies in the Cancer Clinical Trial Centre at the Olivia Newton John Centre, Austin hospital. She works at Ballarat Base hospital and St John of God Hospital as a clinical haematologist.


Dr Maclean graduated from the University of Glasgow, United Kingdom in 2010. She undertook Basic Physician training at Peninsula Health, Victoria; and completed haematology advanced training at Alfred Health, Monash Health, Epworth Health, and Melbourne Pathology. She is a fellow of the Royal College of Physicians Australia and Royal College of Pathologists Australia. She is dedicated to optimal patient-centred care using the latest evidence-based approach.

December 3, 2024
We are pleased to announce palliative care physician Dr Russell Pearce will be joining our team in February 2025.
New haematologist  joining the Ballarat Cancer Care team
August 27, 2024
We are excited to announce Dr Tishya Indran will be joining our team as of 18th September 2024. 
4th Dose COVID-19 Vaccine for Immunocompromised Patients
March 1, 2022
The Australian Technical Advisory Group on Immunisation (ATAGI) has approved a fourth dose of a COVID-19 vaccine for people with weakened immune systems. People aged 18 years or older with weakened immune system who received a 3-dose primary course of the COVID-19 vaccine are now recommended to receive the fourth dose ≥ 3 months after their third dose. This is expected to improve protection against symptomatic infection, serious illness, or death from COVID-19 infection.
COVID-19 Vaccine Booster Shots In Our Patients With Cancer
November 8, 2021
The Government and the Medical advisory group (ATAGI) have release new recommendations last week for individuals who are severely immunocompromised in regards to the COVID-19 vaccine. These recommendations will affect some (but not all) of our patients. As always, we are happy to discuss any of the recommendations further with all of our patients.
COVID-19 Vaccination FAQs July 2021
July 20, 2021
In the last few months, I have been inundated with many questions regarding COVID-19 vaccination and blood clots from patients and other health practitioners. In this article, I have compiled these frequently asked questions.
New PBS listings!
July 2, 2021
Despite a global pandemic, new data relating to oncology treatments continues to be published, and it seems that this is increasingly translating into improved drug access here in Australia.
Astra Zeneca (AZ) vaccine safety information
March 26, 2021
In light of recent reports of clotting events following Astra Zeneca (AZ) vaccine in Europe - we have been frequently asked questions regarding the safety of AZ vaccine in patients with previous clot events and/or blood problems
February 25, 2021
Two vaccines against the coronavirus have now been approved for use in Australia, role-out of the vaccine begins this week in high-risk populations.
January 18, 2021
Dr Swe Myo Htet Consultant Haematologist MBBS, FRACP, FRCPA, MRCP
Blood clot disorder and long distance car-travel
December 2, 2020
Blood specialist, Dr. Pohan Lukito, answers frequently asked question regarding blood clot disorder and long distance car-travel
More Posts
Share by: